VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
---|---|---|---|---|---|---|---|---|
TVIS10018917 | HBV | ENSG00000130413.16 | protein_coding | STK33 | No | No | 65975 | B4DDH2 F8WAK5 Q9BYT3 |
TVIS10012207 | HBV | ENSG00000130413.16 | protein_coding | STK33 | No | No | 65975 | B4DDH2 F8WAK5 Q9BYT3 |
TVIS10038692 | HBV | ENSG00000130413.16 | protein_coding | STK33 | No | No | 65975 | B4DDH2 F8WAK5 Q9BYT3 |
TVIS10046874 | HBV | ENSG00000130413.16 | protein_coding | STK33 | No | No | 65975 | B4DDH2 F8WAK5 Q9BYT3 |
TVIS10050488 | HBV | ENSG00000130413.16 | protein_coding | STK33 | No | No | 65975 | B4DDH2 F8WAK5 Q9BYT3 |
TVIS30074163 | HIV | ENSG00000130413.16 | protein_coding | STK33 | No | No | 65975 | B4DDH2 F8WAK5 Q9BYT3 |
TVIS20049387 | HPV | ENSG00000130413.16 | protein_coding | STK33 | No | No | 65975 | B4DDH2 F8WAK5 Q9BYT3 |
TVIS20018471 | HPV | ENSG00000130413.16 | protein_coding | STK33 | No | No | 65975 | B4DDH2 F8WAK5 Q9BYT3 |
TVIS44017410 | HTLV-1 | ENSG00000130413.16 | protein_coding | STK33 | No | No | 65975 | B4DDH2 F8WAK5 Q9BYT3 |
TVIS44034365 | HTLV-1 | ENSG00000130413.16 | protein_coding | STK33 | No | No | 65975 | B4DDH2 F8WAK5 Q9BYT3 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
Gene | STK33 |
---|---|
DrugBank ID | DB12010 |
Drug Name | Fostamatinib |
Target ID | BE0009386 |
UniProt ID | Q9BYT3 |
Regulation Type | inhibitor |
PubMed IDs | 26516587 |
Citations | Rolf MG, Curwen JO, Veldman-Jones M, Eberlein C, Wang J, Harmer A, Hellawell CJ, Braddock M: In vitro pharmacological profiling of R406 identifies molecular targets underlying the clinical effects of fostamatinib. Pharmacol Res Perspect. 2015 Oct;3(5):e00175. doi: 10.1002/prp2.175. Epub 2015 Sep 4. |
Groups | Approved; Investigational |
Direct Classification | Methoxyanilines |
SMILES | COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC |
Pathways | |
PharmGKB | |
ChEMBL | CHEMBL2103830 |